The latter will test its Keytruda in combination with Agenus' cancer vaccine Prophage. Another competitor is Regeneron which is investigating its own PD-1 inhibitor, REGN2810, alongside two ...

Each journal is staffed by professional editors who work in collaboration with one another and our international Editorial Advisory Boards of leading scientists. Please feel free to contact any of the ...

The EMBO Journal publishes papers describing original research of broad general interest in molecular and cell biology - a particular emphasis is placed on molecular mechanism and physiological ...